Table 2

Effect estimates for the association between interventionist’s experience number (EXPno) per 10 procedures and clinical, radiological, and workflow outcomes

EXPno <45
(n=1285)
EXPno ≥45
(n=1304)
EEUnadjusted
(95% CI)
Adjusted
(95% CI)
Clinical outcomes
 NIHSS score at 24–48 hours, median (IQR)11 (4.0–18), 118710 (4.0–17), 1221β−0.14 (−0.25 to −0.03)−0.09 (−0.20 to 0.01)
 mRS score at 90 days, median (IQR)3 (2-6), 12003 (2-6), 1219cOR0.99 (0.97 to 1.01)0.99 (0.97 to 1.02)
 Mortality at 90 days, n (%)332/1200 (28)357/1219 (29)OR1.00 (0.98 to 1.03)1.00 (0.98 to 1.03)
Safety outcomes, n (%)
 Occurrence any SAEs*541/1285 (42)496/1304 (38)OR0.974 (0.953 to 0.996)0.97 (0.95 to 1.00)
 Stroke progression†124/1285 (9.6)122/1304 (9.4)OR0.99 (0.95 to 1.02)0.98 (0.94 to 1.02)
 New ischemic stroke†16/1285 (1.2)25/1304 (1.9)OR1.08 (1.00 to 1.17)1.06 (0.98 to 1.15)
 Symptomatic ICH*80/1285 (6.2)83/1304 (6.4)OR0.98 (0.94 to 1.03)0.97 (0.93 to 1.02)
Imaging outcomes
 Postinterventional eTICI score, median (IQR)†2B (2A–3), 12622C (2A–3), 1265cOR1.06 (1.04 to 1.08)1.05 (1.02 to 1.08)
 Recanalization, n (%)†741/1262 (59)900/1263 (71)OR1.07 (1.05 to 1.10)1.08 (1.04 to 1.12)
Safety outcomes scored on DSA, n (%)
 Occurrence of procedural complications*200/1285 (16)202/1304 (16)OR1.01 (0.98 to 1.04)0.97 (0.94 to 1.01)
 Dissection†28/1248 (2.2)22/1282 (1.7)OR0.96 (0.89 to 1.05)0.96 (0.88 to 1.05)
 Perforation†23/1248 (1.8)25/1282 (2.0)OR1.01 (0.93 to 1.09)1.01 (0.93 to 1.10)
 Embolus new territory†69/1248 (5.5)64/1272 (5.0)OR0.99 (0.94 to 1.04)0.99 (0.94 to 1.04)
 Distal thrombus†1931248 (16)205/1274 (16)OR1.02 (0.99 to 1.05)1.04 (1.00 to 1.07)
 Vasospasm†81/1248 (6.5)73/1282 (5.7)OR0.98 (0.93 to 1.02)0.98 (0.93 to 1.03)
Workflow outcomes
 Number of attempts, median (IQR)†2.0 (1.0–3.0), 11272.0 (1.0–3.0), 1146β0.017 (−0.002 to 0.036)0.02 (−0.01 to 0.04)
 Duration procedure,
 (min), mean (SD)‡
72 (35), 117867 (34), 1228β−0.84 (−1.22 to -0.46)−1.34 (−1.84 to -0.85)
  • *Additionally adjusted for: clot burden score; ICA stenosis/dissection/occlusion; antiplatelet/DOAC/coumarin/heparin use.

  • †Additionally adjusted for: clot burden score; ICA stenosis/dissection/occlusion.

  • ‡Additionally adjusted for: clot burden score; ICA stenosis/dissection/occlusion; ICA stent placement; general anesthesia.

  • cOR, common odds ratio; DOAC, direct oral anticoagulant; DSA, digital subtraction angiography; EE, effect estimate; eTICI, extended Thrombolysis in Cerebral Infarction; EXPno, experience number; ICA, internal carotid artery; ICH, intracranial hemorrhage; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; SAE, serious adverse event.